- Home
- BBNX
as 10-24-2025 3:54pm EST
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.
Upcoming Earnings Alert:
Get ready for potential market movements as Beta Bionics Inc. Common Stock BBNX prepares to release earnings report on 28 Oct 2025.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | IRVINE |
| Market Cap: | 967.6M | IPO Year: | 2025 |
| Target Price: | $26.09 | AVG Volume (30 days): | 540.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 11 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.35 | EPS Growth: | N/A |
| 52 Week Low/High: | $8.89 - $26.66 | Next Earning Date: | 10-28-2025 |
| Revenue: | $78,022,000 | Revenue Growth: | 550.45% |
| Revenue Growth (this year): | 43.04% | Revenue Growth (next year): | 35.60% |
Latest Beta Bionics Inc. Common Stock News
BBNX Breaking Stock News: Dive into BBNX Ticker-Specific Updates for Smart Investing
GlobeNewswire
16 days ago
Beta Bionics to Announce Third Quarter 2025 Financial Results on October 28, 2025
MT Newswires
24 days ago
Goldman Sachs Upgrades Beta Bionics to Buy From Neutral, Adjusts Price Target to $26 From $18
MT Newswires
a month ago
Truist Raises Price Target on Beta Bionics to $28 From $21, Keeps Buy Rating
GlobeNewswire
4 months ago
Abvance Therapeutics Secures Strategic Seed Financing & Leadership Expansion at ADA Scientific Sessions
MedTech Dive
4 months ago
ADA takeaways: Diabetes tech firms preview new patch pumps, glucose sensors
Zacks
4 months ago
BBNX Stock May Gain From Abbott Deal to Advance iLet Integration
MedTech Dive
4 months ago
5 things to watch at the ADA’s Scientific Sessions
GlobeNewswire
4 months ago
Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott’s Future Dual Glucose-Ketone Sensor
Compare BBNX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BBNX Beta Bionics Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.